Targeting RNA-splicing for SMA treatment.

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• The central dogma (DNA-RNA-protein) has evolved with discoveries like methylation and complex protein modifications.
• RNA undergoes significant regulation, with alternative splicing affecting 80% of pre-mRNA, increasing biological information flow.
• Errors in RNA splicing can lead to protein dysfunction and disease, highlighting the importance of splicing regulation.

Purpose of the Study:

• To review recent advancements in understanding Survival Motor Neuron (SMN) gene splicing.
• To explore the potential of SMN splicing modulation as a therapeutic strategy for Spinal Muscular Atrophy (SMA).

Main Methods:

• Review of current literature on SMN gene splicing mechanisms.
• Analysis of research investigating therapeutic interventions targeting SMN pre-mRNA splicing.
• Synthesis of findings related to exon 7 inclusion in SMN mRNA.

Main Results:

• Alternative splicing of the SMN gene is a critical factor in cellular processes.
• Abnormal SMN splicing is implicated in the pathogenesis of Spinal Muscular Atrophy (SMA).
• Stimulating the inclusion of exon 7 in SMN mRNA is a key therapeutic target for SMA.

Conclusions:

• Targeting SMN splicing represents a viable therapeutic strategy for SMA.
• Continued research into SMN splicing mechanisms is crucial for developing effective SMA treatments.
• Modulating RNA splicing offers a novel approach to treating genetic disorders like SMA.